TB-500 Protocol: Complete Cycling & Dosing Guide

Overview

TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4, functioning as a research compound primarily used for tissue repair, musculoskeletal recovery, and accelerated healing from injury. Its mechanism centers on regulating actin polymerization, promoting angiogenesis through VEGF pathways, modulating inflammatory responses, and reducing fibrosis at injury sites.

Legal Status: TB-500 is not FDA or EMA approved for human use and remains a gray-market research compound in most jurisdictions. This guide is educational and does not constitute medical advice.

Primary Applications:

• Tendon and ligament repair
• Muscle strain and acute injury recovery
• Chronic musculoskeletal injury management
• Post-surgical healing acceleration
• Joint health support in degenerative conditions

The peptide is administered exclusively via injection, with dosing typically ranging from 2.0-2.5 mg twice weekly. Understanding proper cycling, reconstitution, storage, and stacking protocols is essential for optimizing results while minimizing adverse effects.

Standard Protocol

Baseline Dosing Recommendation

Standard maintenance protocol:

• Dose: 2.0-2.5 mg per injection
• Frequency: Twice weekly (3-4 days apart)
• Route: Subcutaneous or intramuscular injection
• Cycle length: 8-12 weeks on, 4-6 weeks off
• Total weekly dose: 4.0-5.0 mg

This represents the most commonly used dosing structure across research communities and observational data. The twice-weekly split allows for steady-state peptide levels while reducing injection frequency burden.

Dose Escalation Protocol

For individuals new to TB-500, a graduated approach minimizes potential transient side effects:

Week 1-2: 1.5 mg twice weekly (3.0 mg/week) Week 3-4: 2.0 mg twice weekly (4.0 mg/week) Week 5+: 2.5 mg twice weekly (5.0 mg/week)

This 3-week ramp allows your system to acclimate to the peptide. Some individuals report reduced fatigue and nausea by progressing gradually rather than starting at full dose immediately.

Reconstitution & Storage

TB-500 arrives as lyophilized (freeze-dried) powder and requires reconstitution before use.

Reconstitution process:

1. Draw bacteriostatic water or 0.9% sodium chloride solution into a sterile syringe
2. Inject 1 mL of solution per 2 mg vial (standard ratio: 1 mL per 2 mg maintains 2 mg/mL concentration)
3. Gently roll vial between palms for 60-90 seconds until fully dissolved—do not shake vigorously
4. Solution should be clear to slightly cloudy; if particles remain, discard
5. Allow 15 minutes for complete stabilization before use

Storage guidelines:

• Refrigerate reconstituted TB-500 at 2-8°C (never freeze after reconstitution)
• Lyophilized powder: store at room temperature, protected from light and moisture
• Reconstituted solution: stable for 14-21 days under proper refrigeration
• Always use sterile, unopened bacteriostatic water; discard vials after 28 days of opening
• Label vials with reconstitution date and discard date

Goal-Specific Protocols

Acute Injury Recovery (Tendon/Ligament/Muscle Strain)

Objective: Accelerate healing of fresh injuries (within 2-4 weeks of occurrence)

Protocol:

• Duration: 12 weeks continuous
• Dosing: 2.5 mg twice weekly (higher end of range)
• Injection timing: Inject on days 1, 4, 8, 11, 15, 18, etc. (consistent 3-4 day spacing)
• Adjuncts: Combine with localized recovery (physical therapy, compression, controlled mobility)
• Expected timeline: Noticeable improvement in inflammation and mobility within 2-3 weeks; substantial functional recovery by week 8-10

Rationale: Higher frequency dosing during acute injury phases maximizes angiogenesis and cellular proliferation at the injury site when tissue remodeling capacity is highest.

Chronic Musculoskeletal Injury or Joint Degeneration

Objective: Support long-term tissue repair and inflammation modulation in established injuries

Protocol:

• Duration: 12-week cycles with 6-week breaks between cycles
• Dosing: 2.0 mg twice weekly (standard maintenance)
• Cycle structure: 12 weeks on, 6 weeks off; repeat as needed
• Stacking consideration: Combine with BPC-157 for synergistic joint support
• Expected timeline: Joint comfort improvements week 3-4; mobility gains by week 8; structural improvements visible in imaging by 12 weeks

Rationale: Chronic conditions require sustained angiogenic and anti-inflammatory support. The 6-week off-cycle prevents tolerance buildup while allowing compound clearance, after which sensitivity is restored.

Performance Enhancement & Flexibility

Objective: Improve connective tissue resilience and movement quality

Protocol:

• Duration: Continuous 8-week cycles with 4-week breaks
• Dosing: 2.0 mg twice weekly
• Timing within training week: Inject Monday and Thursday to allow recovery optimization around heavy training days
• Expected timeline: Improved range of motion by week 3; enhanced recovery sensation by week 5-6

Rationale: Flexible dosing windows around training stress allow TB-500 to support adaptation during high mechanical demand periods.

Post-Surgical Recovery

Objective: Support wound healing and tissue remodeling following surgical intervention

Protocol:

• Start timing: Begin TB-500 within 7-10 days post-surgery (after initial surgical wound healing begins)
• Duration: 10-12 weeks
• Dosing: 2.5 mg twice weekly for weeks 1-6, taper to 2.0 mg twice weekly for weeks 7-12
• Frequency: Maintain consistent 3-4 day spacing
• Important: Consult prescribing surgeon before initiating; TB-500 may interact with specific surgical protocols

Rationale: Early-phase surgery recovery benefits from maximal angiogenic support; later phases require lighter maintenance as primary healing concludes.

How to Administer Step-by-Step

Injection Technique (Subcutaneous)

Materials needed:

• Reconstituted TB-500 (2 mg/mL concentration)
• 27-30 gauge insulin syringe (0.5-1 mL)
• Sterile alcohol pad
• Sharps disposal container

Procedure:

1. Draw up the prescribed dose (e.g., 1 mL for 2 mg dose) into syringe, ensuring no air bubbles
2. Select injection site: lower abdomen (1-2 inches lateral from navel), upper thigh, or upper arm
3. Rotate sites to prevent tissue irritation; never inject into same location twice in one week
4. Clean injection site with alcohol pad using circular motions; wait 30 seconds for drying
5. Pinch skin fold between thumb and forefinger to create raised tissue
6. Insert needle at 45-90 degree angle, depending on subcutaneous depth at site
7. Depress plunger steadily over 5-10 seconds
8. Withdraw needle slowly and apply gentle pressure for 10 seconds
9. Massage area lightly for 30 seconds to promote distribution

Injection Site Rotation Schedule

Maintain a rotation pattern to prevent localized irritation:

Week 1-2: Right lower abdomen, Left lower abdomen Week 3-4: Right upper thigh, Left upper thigh Week 5-6: Right upper arm, Left upper arm Week 7+: Repeat pattern

This ensures each site receives minimum 3-4 weeks between injections at the same location.

Timing Considerations

• Best timing: Inject in morning to evening, consistency matters more than time of day
• Spacing: Maintain 3-4 day intervals; Monday-Thursday or Tuesday-Friday patterns work well
• Post-injection: Light activity acceptable; avoid intense training for 4-6 hours post-injection to minimize transient fatigue

Cycle Example: 12-Week Injury Recovery Protocol

What to Expect: Timeline of Effects

Days 1-3

• Minimal noticeable effects
• Possible transient fatigue or mild lethargy 2-4 hours post-injection in first 1-2 administrations
• Minor injection site redness or swelling (typically resolves within hours)

Week 1-2

• Reduced acute inflammation at injury site (if applicable)
• Slight improvement in range of motion or joint comfort
• Most individuals report adaptation to injection routine

Week 3-4

• Notable reduction in pain or discomfort with activity
• Improved morning stiffness or joint mobility
• Increased tissue pliability and flexibility; reduced muscle guarding
• Most significant window for dose assessment and adjustment

Week 5-8

• Substantial functional improvements in injury recovery
• Enhanced connective tissue resilience
• Improved recovery sensation after training or activity
• Visible tissue remodeling if monitored with imaging

Week 8-12

• Consolidation of healing gains
• Return to baseline or improved baseline function
• Reduced dependency on pain management or mobility aids
• Optimal window for reassessing need for continued cycling

Post-Cycle (Weeks 13-18)

• Continued slow improvements as remodeling completes
• Benefits typically persist for 4-12 weeks after cycle completion
• Fatigue and injection-related side effects resolve completely

Common Protocol Mistakes

1. Injecting at Same Site Too Frequently

Problem: Repeated injections at identical locations cause localized fibrosis, abscess risk, and reduced absorption Solution: Follow strict site rotation schedule (minimum 3-4 weeks between same site)

2. Starting at Excessive Dosing

Problem: Jumping to 2.5 mg twice weekly without ramp-up increases nausea, fatigue, and headache risk Solution: Use 3-week escalation protocol (1.5 mg → 2.0 mg → 2.5 mg)

3. Inadequate Reconstitution

Problem: Vigorous shaking denatures peptide; dissolved particles indicate contamination Solution: Roll gently for 60-90 seconds; allow 15-minute stabilization before use

4. Using Reconstituted Peptide Beyond Shelf Life

Problem: Bacterial growth in bacteriostatic water and peptide degradation reduce efficacy Solution: Discard reconstituted vials after 21 days; track reconstitution dates

5. Inconsistent Injection Spacing

Problem: Irregular intervals (e.g., 2 days one week, 5 days the next) prevent steady-state levels Solution: Set calendar reminders for Monday and Thursday (or Tuesday/Friday); treat as non-negotiable

6. Cycling Off Too Briefly

Problem: 2-3 week breaks insufficient for system reset and tolerance restoration Solution: Minimum 4-week off-cycles; 6-8 weeks preferred for chronic protocols

7. Neglecting Localized Therapy

Problem: Expecting TB-500 alone to heal injuries without physical therapy, mobility work, or activity modification Solution: Use TB-500 as enhancement to established recovery protocols, not replacement

8. Exceeding 2.5 mg per Injection Without Medical Guidance

Problem: No human data above 2.5 mg twice weekly; higher doses increase side effect risk without proven benefit Solution: Stay within 2.0-2.5 mg range; if inadequate response, extend cycle length rather than increase dose

How to Stack with Other Compounds

TB-500 + BPC-157 (Synergistic Joint Protocol)

Purpose: Maximize tendon/ligament/joint recovery

• TB-500: 2.0 mg twice weekly
• BPC-157: 250-500 mcg daily (separate injection)
• Cycle: 12 weeks concurrent, 6 weeks off
• Rationale: TB-500 promotes angiogenesis; BPC-157 enhances epithelial repair. Non-overlapping mechanisms provide complementary benefits for joint and connective tissue integrity

TB-500 + HGH (Growth Hormone) (Recovery Optimization)

Purpose: Accelerate whole-body recovery and tissue remodeling

• TB-500: 2.0 mg twice weekly
• HGH: 2-4 IU daily (separate timing)
• Cycle: TB-500 for 12 weeks, HGH continuous or periodic cycling
• Rationale: HGH enhances anabolic signaling systemically; TB-500 localizes repair response at injury sites. Synergistic for post-surgical or severe injury recovery
• Caution: Combined angiogenic properties increase theoretical oncological risk; avoid if cancer history or suspicious masses present

TB-500 + Low-Dose Testosterone (Performance & Connective Tissue)

Purpose: Support muscle quality, connective tissue resilience, and recovery

• TB-500: 2.0-2.5 mg twice weekly
• Testosterone: Therapeutic replacement or mild supraphysiological doses (e.g., 125-250 mg/week)
• Cycle: 8-12 week concurrent cycles with 4-6 week breaks
• Rationale: Testosterone supports muscle protein synthesis and collagen turnover; TB-500 accelerates tissue remodeling. Effective for athletes returning from injury seeking performance restoration
• Caution: Do not combine with orally active anabolic agents due to increased hepatic stress

TB-500 Standalone (Safest Approach)

Purpose: Maximize efficacy of single compound while minimizing interaction risk

• TB-500: 2.0-2.5 mg twice weekly
• Cycle: 8-12 weeks on, 4-6 weeks off
• Rationale: Most reversible protocol with clearest side effect attribution. Recommended for first-time users or individuals with comorbidities

Protocol Quick Reference Table